MoonLake Immunotherapeutics: Funding, Investors & Team (Sep 2026)
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new therapies and harnessing the potential of Sonelokimab, a novel investigational Nanobody®, to transform results for patients experiencing inflammation.
MoonLake Immunotherapeutics has raised $350M across 3 funding rounds on record, the most recent an undisclosed round of $200M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MoonLake Immunotherapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
MoonLake Immunotherapeutics Funding Rounds
MoonLake Immunotherapeutics raised $75.0M in an undisclosed round announced in Apr 2025.
7 months later, an undisclosed round of $75.0M was announced in Nov 2025.
7 months later, an undisclosed round of $200M was announced in Jun 2026.
MoonLake Immunotherapeutics Founders and Leadership Team
No contact details are on record for this team yet.
MoonLake Immunotherapeutics Funding Compared to Other Biotechnology Startups
MoonLake Immunotherapeutics' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MoonLake Immunotherapeutics in Biotechnology and Zug
Companies Similar to MoonLake Immunotherapeutics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Pharvaris is a clinical-stage company working on bringing a new oral bradykinin B2 receptor antagonist to…
MoonLake Immunotherapeutics Funding FAQs
What does MoonLake Immunotherapeutics do?
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new therapies and harnessing the potential of Sonelokimab, a novel investigational Nanobody®, to transform results for patients experiencing inflammation.
How much funding has MoonLake Immunotherapeutics raised?
MoonLake Immunotherapeutics has raised $350M across 3 rounds on record. The most recent is an undisclosed round of $200M announced in Jun 2026.
When did MoonLake Immunotherapeutics last raise funding?
MoonLake Immunotherapeutics' most recent funding round on record is an undisclosed round of $200M, announced in Jun 2026.
Who founded MoonLake Immunotherapeutics?
FundedIQ lists Jorge Santos (Founder), Jorge Silva (Founder) at MoonLake Immunotherapeutics.
Where is MoonLake Immunotherapeutics headquartered?
MoonLake Immunotherapeutics is based in Zug, Switzerland.
How many employees does MoonLake Immunotherapeutics have?
MoonLake Immunotherapeutics is in the 101-250 employee band.
How does MoonLake Immunotherapeutics' funding compare to other Biotechnology startups?
MoonLake Immunotherapeutics' latest round of $200M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MoonLake Immunotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MoonLake Immunotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.